Dec 10 · McLean, VA: Network with investors and see emerging startups pitch live. Register →

The Lead Investor Paradox: Everyone Wants In. Nobody Wants to Go First.

Tien Wong, Founder and Executive Chairman, CONNECTpreneur | November 19, 2026

Why finding a lead investor is the hardest part of many private financings—and how to find, cultivate, and close one.

One of the most frustrating phenomena I encounter in private capital markets is a company with substantial investor interest, sometimes enough to cover its entire financing, yet no ability to close the round.

Consider a company raising $20 million, or even $10 million. Management has spent months meeting with family offices, venture capital funds, and other private investors. Several have reviewed the investment materials, expressed genuine enthusiasm, and indicated they could participate with checks ranging from $500,000 to several million dollars. Collectively, the potential investments could exceed the amount the company is seeking.

Yet six months later, the financing remains open.

The reason is remarkably consistent. Nearly every investor delivers some version of the same message: “We like the company and would be interested in participating, but we’d like to see a lead investor in place first.”

This is what I call the Lead Investor Paradox: A company can have enough interested investors to fill its financing, but if nobody is willing to lead, all that potential capital may remain on the sidelines.

It’s a problem I see particularly often among companies raising $10 million to $50 million, where financing requirements can exceed the appetite of individual investors while the company may not fit neatly within the mandates of larger institutional funds.

The irony is that many of these companies don’t necessarily have a shortage of interested investors. They have a shortage of investors willing to make the first consequential decision.

 

The Investor Everyone Needs but Few Want to Be

In private capital markets, there is an important distinction between investors who lead a financing and those who prefer to follow. A lead investor typically takes responsibility for independently evaluating the opportunity, negotiating principal investment terms, assessing valuation, and conducting or coordinating the diligence necessary to move the transaction forward.

Equally important, a credible lead investor provides validation that can give other prospective investors the confidence to participate. Their commitment may establish the framework around which an entire syndicate forms.

Follower investors may be genuinely attracted to the company, but prefer to invest alongside an established lead rather than make the initial commitment themselves. This is entirely rational in many circumstances, particularly when investors lack the resources, sector expertise, or inclination to conduct extensive independent diligence.

The difficulty arises when nearly everyone prefers to follow. Each investor waits for someone else to validate the opportunity, establish terms, and commit capital. The result is a financing that appears to have substantial support but remains unable to move forward.

 

Why Investors Don’t Want to Lead: The First-Mover Tax

There are several reasons why investors hesitate to lead financings, and understanding these motivations is essential for founders seeking to overcome the problem.

First, leading requires considerably more work than following. A lead investor may need to evaluate the company’s business model, technology, management team, financial projections, competitive position, and principal risks. In more complex sectors such as biotechnology and medical technology, the process may also involve extensive scientific, clinical, regulatory, and reimbursement diligence.

Second, the lead investor assumes pricing and structuring responsibility. Establishing an appropriate valuation, negotiating investment protections, and determining financing terms can be difficult without another sophisticated investor providing a reference point.

Third, the lead faces syndication risk. An investor contemplating a $3 million commitment to a $20 million financing may worry that the remaining $17 million will never materialize, leaving the company undercapitalized or forcing an additional financing on unfavorable terms.

Finally, there is reputational and career risk. An investor who leads an unsuccessful investment may face greater scrutiny than one who merely participated alongside an established institution. Even experienced investors are not immune to the influence of social proof and the comfort of investing with other respected capital providers.

Consider two investors evaluating the same $20 million financing. Both are prepared to invest $2 million, but one agrees to lead while the other waits for the financing to be organized. The lead may spend months conducting diligence, negotiating terms, and helping assemble the syndicate, while the follower benefits from much of that work.

Yet both may ultimately receive substantially similar economic terms.

I think of this imbalance as the first-mover tax. The lead investor incurs costs and responsibilities that benefit the entire syndicate, while followers can capture much of that benefit without bearing the same burden.

From the perspective of an individual investor, waiting can be perfectly rational. But when every investor makes the same rational decision, the collective result becomes irrational: a potentially attractive financing that nobody is willing to initiate.

 

The Most Valuable Investor May Not Write the Biggest Check

One of the less obvious implications is that the value of a prospective investor cannot be measured solely by the size of the check they might write.

A sophisticated investor willing to commit $1 million, establish credible financing terms, and help organize a syndicate may be considerably more valuable than a prospective $5 million investor who refuses to participate until someone else takes the lead.

The first investor’s commitment can unlock the second investor’s capital, along with commitments from others. Under the right circumstances, a relatively modest initial investment can become the catalyst for a much larger financing.

This is why I believe founders should distinguish between the financial capacity of an investor and their ability to catalyze a financing. They are not necessarily the same thing.

The most valuable investor isn’t always the one with the deepest pockets. It’s the one whose conviction makes other capital move.

 

How to Find, Cultivate, and Close a Lead Investor

Breaking the lead-investor deadlock requires a different strategy from simply generating more investor introductions. Founders need to identify investors capable of leading, understand what prevents them from doing so, and sometimes rethink the financing structure or economics to make taking the lead worthwhile.

Here are several approaches that can materially improve the likelihood of securing a lead investor.

1. Target Investors Who Have Actually Led Comparable Financings

Rather than concentrating exclusively on assets under management or potential check size, examine investors’ prior transactions. Have they led financings in your industry? Have they negotiated terms and anchored similarly sized rounds? Do they have the internal expertise, investment authority, and resources to underwrite an opportunity independently?

An investor with a history of leading comparable transactions is generally a more promising prospect than a much larger institution that participates almost exclusively alongside established sponsors.

This requires more targeted research than simply assembling a list of investors interested in your sector. It also means distinguishing between investors who make decisions independently and those whose investment processes depend on external validation or syndicate participation.

Early conversations should establish whether an investor is willing and able to lead, what their typical investment parameters look like, and how their decision-making process works.

2. Understand Why the Investor Is Reluctant to Go First

An investor’s reluctance may have little to do with the fundamental attractiveness of the company. They may be concerned about valuation, diligence costs, regulatory uncertainty, the company’s capital requirements, or whether the balance of the financing can be completed.

The most productive conversation is not necessarily another presentation about the company’s growth prospects. It is a direct discussion about the specific issues preventing the investor from making a commitment.

I believe this is one of the most overlooked aspects of fundraising. Once a serious investor understands the opportunity, continuing to emphasize the upside may accomplish very little. At that stage, the founder needs to identify the two or three obstacles standing between investor interest and an actual decision.

If valuation is the problem, perhaps the financing structure needs to be revisited. If the investor is concerned about regulatory risk, independent expert validation may help. If the concern is whether the company can raise the remainder of the round, a credible syndication plan becomes essential.

The objective is no longer simply to make the investor more enthusiastic. It is to remove the reasons an interested investor cannot say yes.

Founders should also recognize when an investor fundamentally lacks conviction. No amount of restructuring or additional diligence will necessarily convert someone who simply doesn’t believe in the opportunity.

3. Consider Rewarding Investors for Taking the Lead

Here is a question that founders sometimes overlook: If the lead investor assumes greater responsibility, incurs additional diligence costs, and helps unlock substantial capital from other investors, should that investor necessarily receive exactly the same economics as everyone who follows?

Not always.

Depending on the circumstances, a company might consider offering a meaningful lead investor warrants, preferential pricing, negotiated governance rights, enhanced information rights, or additional participation rights in future financings.

Super pro rata rights, for example, could give a lead investor the opportunity to increase its ownership beyond its existing proportional stake in subsequent financing rounds, subject to negotiated limitations. For an investor who believes strongly in the company’s future, the ability to deploy additional capital as the business achieves milestones may be particularly attractive.

Warrants or other economic incentives may also be appropriate in certain transactions, particularly where a lead investor is assuming meaningful responsibilities or helping assemble a larger syndicate.

These arrangements must be structured carefully. Excessive discounts, onerous liquidation preferences, or overly generous future investment rights can dilute existing shareholders, create conflicts among investors, and complicate subsequent financings. Any differentiated terms should also be reviewed by experienced securities counsel.

The objective is not to give away economics simply to manufacture investor interest. It is to recognize that an investor who helps make a financing possible may contribute substantially more than the amount of their initial check.

If investors are reluctant to pay the first-mover tax, companies should consider whether there is an economically sensible way to compensate them for taking the lead.

4. Make the Investment Easier to Underwrite—and Easier to Complete

Because lead investors bear a disproportionate share of the diligence burden, companies should make the process as efficient and transparent as possible.

This means maintaining a well-organized data room, providing credible financial projections, clearly articulating the use of proceeds, anticipating difficult diligence questions, and making management and relevant outside experts available when needed.

For companies in highly regulated or technically complex sectors, independent validation can be especially important. A credible assessment of clinical results, intellectual property, regulatory pathways, reimbursement prospects, or commercial adoption may help resolve concerns that management presentations alone cannot address.

Equally important, prospective leads need confidence that the overall financing can actually close. A $3 million commitment to a $20 million round may be unattractive if the remaining $17 million is highly uncertain.

Founders should therefore provide a realistic picture of syndication prospects, distinguishing between preliminary investor interest, active diligence, and genuine commitments. Credible evidence of prospective co-investor demand can help reduce financing uncertainty, but overstating that interest can quickly undermine trust.

A well-managed financing process also benefits from clear diligence milestones, timely follow-up, and a mutually understood path toward an investment decision.

5. Consider Changing the Financing Structure Rather Than Continuing to Search for the Perfect Lead

Perhaps the most counterintuitive solution is to reconsider whether the company actually needs one investor to lead the entire transaction.

A company seeking $20 million might consider an initial closing of $5 million or $7 million, followed by additional closings as other investors complete diligence. Alternatively, the company might assemble two or three credible anchor investors who collectively establish the financing terms and share the responsibilities traditionally associated with a single lead.

Milestone-based financings offer another possibility. Rather than requiring the entire amount to be funded immediately, capital can be structured around defined operational, clinical, regulatory, or commercial milestones. This may make the investment more attractive to investors who are reluctant to commit the full amount before certain risks have been reduced.

These approaches are not appropriate for every company. Smaller initial closings may leave a business undercapitalized, while milestone-dependent financing can create additional execution risk if subsequent funding does not materialize. Multiple anchor investors may also complicate negotiations unless responsibilities and decision-making authority are clearly established.

Nevertheless, a responsibly structured financing can sometimes achieve what months of additional investor outreach cannot.

Sometimes the best way to find a lead investor is to stop insisting that one investor must lead the entire round.

The broader lesson is that financing structures should reflect the investment behavior of the capital providers being targeted, rather than forcing every transaction into a conventional model that may not fit the circumstances.

6. Convert Investor Interest Into a Definitive Commitment

Finding a credible prospective lead and generating serious interest are important milestones, but neither guarantees that a financing will close.

Once an investor has demonstrated genuine interest, management should shift from presenting the opportunity to managing a disciplined process toward commitment.

This means understanding the investor’s internal approval requirements, identifying unresolved diligence issues, negotiating the principal economic terms, and establishing a realistic timetable for reaching a decision.

Founders should also pay attention to the investor’s behavior, not merely their expressions of enthusiasm. An investor who engages substantively with diligence, involves legal counsel, provides detailed feedback on terms, and establishes a clear investment approval process is demonstrating a different level of commitment from one who repeatedly requests additional meetings without advancing the discussion.

Where there is genuine alignment, the process should move toward an agreed term sheet, completion of confirmatory diligence, definitive documentation, and ultimately a funded closing.

A term sheet is an important milestone, but even a signed term sheet is not the same as capital in the bank.

A lead investor isn’t simply found through networking. A credible lead must be identified, cultivated, motivated, and ultimately converted into an actual capital commitment.

Beware the Illusion of Investor Interest

There is another uncomfortable dimension to the Lead Investor Paradox. Not every investor who expresses interest in participating once a lead is secured actually intends to invest.

Sometimes the interest is genuine. An investor may require independently negotiated terms, external validation, or an established institution willing to anchor the financing.

In other cases, however, the request for a lead investor becomes a convenient way to defer a decision without explicitly rejecting the opportunity. It’s often easier to tell an enthusiastic founder, “Come back when you have a lead,” than to explain that the opportunity hasn’t generated sufficient conviction to justify an investment.

The result can be a misleading picture of fundraising progress. A CEO may report to the board that the company has $15 million of interest toward a $20 million financing, even though virtually all of that interest is conditional on securing a lead.

Those expressions of interest may ultimately translate into meaningful commitments, but they may also evaporate when investors are finally asked to make a decision.

Founders should therefore distinguish carefully between investor enthusiasm, conditional interest, and genuine investment intent. These represent very different stages of capital formation, yet are frequently treated as interchangeable.

A financing pipeline can look exceptionally strong on paper while remaining surprisingly weak in terms of capital that is actually ready to be deployed.

 

The Real Scarcity in Private Capital

We frequently hear about the enormous amounts of capital managed by family offices, venture funds, private equity firms, and other private investors. While that capital is substantial, its existence doesn’t necessarily mean it is readily accessible to companies seeking financing.

Capital must still be evaluated, allocated, and committed by individuals or investment committees willing to exercise independent judgment and accept the associated risks. In many transactions, the challenge is not simply identifying investors with sufficient financial resources, but finding those prepared to make the initial decision that enables others to follow.

For founders confronting this problem, the solution is rarely to accumulate another 50 investor introductions without changing their approach. It is to identify credible prospective leads, understand what motivates them, address their underwriting concerns, and consider whether the financing structure appropriately rewards the responsibilities associated with leading.

And when those approaches fail, founders should be prepared to question the assumption that a financing requires one traditional lead investor in the first place. Multiple anchors, staged closings, and appropriately structured milestone-based financings may offer alternative paths, provided the company can maintain sufficient funding certainty.

Ultimately, fundraising progress should not be measured primarily by the number of investors expressing interest or even the aggregate dollar value of potential participation. What matters is whether a company can attract investors prepared to make decisions, commit capital, and help move the financing toward closing.

In private capital markets, 100 investors willing to follow may be worth less than one investor willing to lead.

And that is the Lead Investor Paradox: The money may be there, the interest may be genuine, and the opportunity may be attractive. But until someone is willing to go first—or the company finds another way to get the financing moving—the capital may remain on the sidelines indefinitely.

For those actively raising or deploying private capital, I’m interested in your perspective: Is the shortage of willing lead investors becoming a greater obstacle to completing financings than the availability of capital itself?